DUBLIN, Ireland, Nov. 06, 2017 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (NASDAQ:AVDL), today announced it will host an analyst and investor meeting to focus on its new product, Noctiva™, on Monday, November 13, 2017 in New York City. The presentation will take place from approximately 8:00 a.m. – 10:00 a.m. EST. In-person attendance requires advanced registration.